US Breakthrough Drugs Show No Signs Of Slowing
This article was originally published in SRA
Executive Summary
At least 11 new breakthrough therapy designations have been announced in the first seven weeks of 2016, as the US Food and Drug Administration's expedited review program's popularity continues to rise at a fast pace.